VRK2 Gene

Name vaccinia related kinase 2
Description This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. The encoded protein acts as an effector of signaling pathways that regulate apoptosis and tumor cell growth. Variants in this gene have been associated with schizophrenia. Alternative splicing results in multiple transcript variants that differ in their subcellular localization and biological activity. [provided by RefSeq, Jan 2014]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nVaccinia‐related kinase 2 (VRK2) is a serine/threonine kinase that exists in functionally distinct isoforms—with VRK2A tethered to the endoplasmic reticulum and mitochondrial membranes and VRK2B distributed in the cytosol and nucleus—which modulate key cellular signaling events. VRK2 phosphorylates targets such as p53 (at Thr18) and interacts with several partners to fine‐tune stress‐activated cascades; for example, it associates with Ran to regulate related kinase activities, forms stable complexes with scaffolding proteins (e.g. KSR1 and MEK1) to modulate MAPK/ERK signaling, and phosphorylates transcriptional regulators such as NFAT1 that subsequently affect proinflammatory genes. In addition, VRK2 influences protein homeostasis through the regulation of chaperonin complexes (e.g. TRiC) via ubiquitin–proteasome pathways and directly interacts with anti‐apoptotic factors like Bcl‑xL. These molecular interactions and modifications underscore VRK2’s role as an integrator of mitogenic, stress, and apoptotic signals."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA wealth of genetic and expression studies have linked VRK2 to neuropsychiatric and neurodevelopmental disorders. Genome‑wide association studies and targeted SNP analyses in diverse populations have implicated variants in VRK2 with schizophrenia, epilepsy, and major depression, with some risk alleles also correlating with alterations in brain structure and sleep/circadian parameters. Moreover, altered VRK2 expression has been observed in peripheral blood and brain tissues from patients with these disorders, suggesting that VRK2-mediated modulation of intracellular signaling may contribute to abnormal neuronal development, synaptic function, and overall neural network connectivity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of oncogenesis and therapeutic response, VRK2 exerts multifaceted effects that influence cell proliferation, apoptosis, and drug sensitivity. Through its ability to interact with viral proteins (such as EBV BHRF1) and to alter key signaling pathways—including modulation of MAPK/ERK, NF‑κB, and lysosome‐associated Akt signaling—VRK2 can contribute to tumor cell survival and chemoresistance in cancers such as rectal, breast, hepatocellular, and pancreatic carcinomas. Furthermore, VRK2 levels have been linked to synthetic lethal interactions in neural tumors, and emerging structural data have paved the way for the development of selective small‑molecule inhibitors aimed at targeting VRK2’s kinase activity to perturb its pro‑survival signaling in cancer cells."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Sandra Blanco, Lucia Klimcakova, Francisco M Vega, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1742-4658.2006.05256.x"}], "href": "https://doi.org/10.1111/j.1742-4658.2006.05256.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16704422"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16704422"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sandra Blanco, Claudio Santos, Pedro A Lazo "}, {"type": "b", "children": [{"type": "t", "text": "Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00025-07"}], "href": "https://doi.org/10.1128/MCB.00025-07"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17709393"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17709393"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Sandra Blanco, Marta Sanz-García, Claudio R Santos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0001660"}], "href": "https://doi.org/10.1371/journal.pone.0001660"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18286207"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18286207"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Marta Sanz-García, Inmaculada López-Sánchez, Pedro A Lazo "}, {"type": "b", "children": [{"type": "t", "text": "Proteomics identification of nuclear Ran GTPase as an inhibitor of human VRK1 and VRK2 (vaccinia-related kinase) activities."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Proteomics (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/mcp.M700586-MCP200"}], "href": "https://doi.org/10.1074/mcp.M700586-MCP200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18617507"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18617507"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Isabel F Fernández, Luis G Pérez-Rivas, Sandra Blanco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Life Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00018-012-1056-8"}], "href": "https://doi.org/10.1007/s00018-012-1056-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22752157"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22752157"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Marta Vázquez-Cedeira, Pedro A Lazo "}, {"type": "b", "children": [{"type": "t", "text": "Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.404285"}], "href": "https://doi.org/10.1074/jbc.M112.404285"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23105117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23105117"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "D M Monsalve, T Merced, I F Fernández, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2013.40"}], "href": "https://doi.org/10.1038/cddis.2013.40"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23449449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23449449"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Sangjune Kim, Do-Young Park, Dohyun Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vaccinia-related kinase 2 mediates accumulation of polyglutamine aggregates via negative regulation of the chaperonin TRiC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00756-13"}], "href": "https://doi.org/10.1128/MCB.00756-13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24298020"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24298020"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Sangjune Kim, Dohyun Lee, Juhyun Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vaccinia-Related Kinase 2 Controls the Stability of the Eukaryotic Chaperonin TRiC/CCT by Inhibiting the Deubiquitinating Enzyme USP25."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01325-14"}], "href": "https://doi.org/10.1128/MCB.01325-14"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25755282"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25755282"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Annabel T Olson, Amber B Rico, Zhigang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.00635-17"}], "href": "https://doi.org/10.1128/JVI.00635-17"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28515294"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28515294"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Rafael M Couñago, Charles K Allerston, Pavel Savitsky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural characterization of human Vaccinia-Related Kinases (VRK) bound to small-molecule inhibitors identifies different P-loop conformations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-07755-y"}], "href": "https://doi.org/10.1038/s41598-017-07755-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28790404"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28790404"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Stacy Steinberg, Simone de Jong, Ole A Andreassen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Common variants at VRK2 and TCF4 conferring risk of schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddr325"}], "href": "https://doi.org/10.1093/hmg/ddr325"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21791550"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21791550"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Michael Steffens, Costin Leu, Ann-Kathrin Ruppert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/dds373"}], "href": "https://doi.org/10.1093/hmg/dds373"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22949513"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22949513"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ming Li, Yi Wang, Xue-bin Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Schizophr Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.schres.2012.10.008"}], "href": "https://doi.org/10.1016/j.schres.2012.10.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23102693"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23102693"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Hoyoung Sohn, Borah Kim, Keun Hyang Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of VRK2 (rs2312147) on white matter connectivity in patients with schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0103519"}], "href": "https://doi.org/10.1371/journal.pone.0103519"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25079070"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25079070"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "B Zhang, C Y Gao, H B Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of the VRK2 gene rs3732136 polymorphism with schizophrenia in a Northwest Chinese Han population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Mol Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4238/2015.August.14.4"}], "href": "https://doi.org/10.4238/2015.August.14.4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26345874"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26345874"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Martin Tesli, Katrine Verena Wirgenes, Timothy Hughes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VRK2 gene expression in schizophrenia, bipolar disorder and healthy controls."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Psychiatry (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1192/bjp.bp.115.161950"}], "href": "https://doi.org/10.1192/bjp.bp.115.161950"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26941264"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26941264"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Samuel E Jones, Jessica Tyrrell, Andrew R Wood, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-Wide Association Analyses in 128,266 Individuals Identifies New Morningness and Sleep Duration Loci."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1006125"}], "href": "https://doi.org/10.1371/journal.pgen.1006125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27494321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27494321"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Eunju Lee, Hye Guk Ryu, Sangjune Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glycogen synthase kinase 3β suppresses polyglutamine aggregation by inhibiting Vaccinia-related kinase 2 activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep29097"}], "href": "https://doi.org/10.1038/srep29097"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27377031"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27377031"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Hong Chang, Chen Zhang, Xiao Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Further evidence of VRK2 rs2312147 associated with schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Biol Psychiatry (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15622975.2016.1200746"}], "href": "https://doi.org/10.1080/15622975.2016.1200746"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27382989"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27382989"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "H Yu, H Yan, J Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mp.2016.212"}], "href": "https://doi.org/10.1038/mp.2016.212"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27922604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27922604"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Tahereh Azimi, Soudeh Ghafouri-Fard, Mir Davood Omrani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vaccinia Related Kinase 2 (VRK2) expression in neurological disorders: schizophrenia, epilepsy and multiple sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mult Scler Relat Disord (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.msard.2017.10.017"}], "href": "https://doi.org/10.1016/j.msard.2017.10.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29100046"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29100046"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Young-Hun Jeong, Jung-Hyun Choi, Dohyun Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vaccinia-related kinase 2 modulates role of dysbindin by regulating protein stability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jnc.14562"}], "href": "https://doi.org/10.1111/jnc.14562"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30062698"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30062698"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xianglai Liu, Tianming Han, Hailing Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of the relationship between VRK2, rs4380187 polymorphisms, and genetic susceptibility to schizophrenia in the Chinese Han population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gene Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jgm.3313"}], "href": "https://doi.org/10.1002/jgm.3313"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33522046"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33522046"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Mei-Yu Yin, Lei Guo, Li-Juan Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced Vrk2 expression is associated with higher risk of depression in humans and mediates depressive-like behaviors in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12916-023-02945-0"}], "href": "https://doi.org/10.1186/s12916-023-02945-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37452335"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37452335"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Long-Yuan Li, Mei-Ying Liu, Hsiu-Ming Shih, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gen Virol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1099/vir.0.81953-0"}], "href": "https://doi.org/10.1099/vir.0.81953-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16963744"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16963744"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Isabel F Fernández, Sandra Blanco, José Lozano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01581-09"}], "href": "https://doi.org/10.1128/MCB.01581-09"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20679487"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20679487"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Laura Del Puerto-Nevado, Juan Pablo Marin-Arango, Maria Jesus Fernandez-Aceñero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-016-2574-9"}], "href": "https://doi.org/10.1186/s12885-016-2574-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27456229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27456229"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Noriyuki Hirata, Futoshi Suizu, Mami Matsuda-Lennikov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional characterization of lysosomal interaction of Akt with VRK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-018-0330-0"}], "href": "https://doi.org/10.1038/s41388-018-0330-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29872222"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29872222"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Sisi Chen, Yunyan Du, Bin Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vaccinia-related kinase 2 blunts sorafenib's efficacy against hepatocellular carcinoma by disturbing the apoptosis-autophagy balance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-021-01780-y"}], "href": "https://doi.org/10.1038/s41388-021-01780-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33875785"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33875785"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jionghuang Chen, Kexiong Qiao, Chaolei Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VRK2 activates TNFα/NF-κB signaling by phosphorylating IKKβ in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.66313"}], "href": "https://doi.org/10.7150/ijbs.66313"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35173553"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35173553"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Jonathan So, Nathaniel W Mabe, Bernhard Englinger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous system."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JCI Insight (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/jci.insight.158755"}], "href": "https://doi.org/10.1172/jci.insight.158755"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36040810"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36040810"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Rashmi Puja, Shubhankar Dutta, Kakoli Bose "}, {"type": "b", "children": [{"type": "t", "text": "Elucidating the interaction of C-terminal domain of Vaccinia-Related Kinase 2A (VRK2A) with B-cell lymphoma-extra Large (Bcl-xL) to decipher its anti-apoptotic role in cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BCJ20230349"}], "href": "https://doi.org/10.1042/BCJ20230349"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37943248"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37943248"}]}]}]}
Proteins VRK2_HUMAN
NCBI Gene ID 7444
API
Download Associations
Predicted Functions View VRK2's ARCHS4 Predicted Functions.
Co-expressed Genes View VRK2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View VRK2's ARCHS4 Predicted Functions.

Functional Associations

VRK2 has 7,205 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 122 datasets.

Click the + buttons to view associations for VRK2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of VRK2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of VRK2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of VRK2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of VRK2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of VRK2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of VRK2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of VRK2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of VRK2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of VRK2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of VRK2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of VRK2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of VRK2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Gene Mutation Profiles cell lines with VRK2 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with VRK2 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with VRK2 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of VRK2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of VRK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of VRK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with VRK2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of VRK2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of VRK2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing VRK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing VRK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores cellular components containing VRK2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing VRK2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with VRK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with VRK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of VRK2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with VRK2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Disease Associations diseases associated with VRK2 gene/protein from the curated CTD Gene-Disease Associations dataset.
dbGAP Gene-Trait Associations traits associated with VRK2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of VRK2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by VRK2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores diseases associated with VRK2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with VRK2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with VRK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with VRK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with VRK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with VRK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at VRK2 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of VRK2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of VRK2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing VRK2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with VRK2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with VRK2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of VRK2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with VRK2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing VRK2 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of VRK2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of VRK2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of VRK2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of VRK2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of VRK2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of VRK2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving VRK2 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving VRK2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving VRK2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing VRK2 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing VRK2 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing VRK2 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by VRK2 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by VRK2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by VRK2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of VRK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of VRK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of VRK2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of VRK2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations phenotypes associated with VRK2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with VRK2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with VRK2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with VRK2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of VRK2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for VRK2 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of VRK2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of VRK2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of VRK2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of VRK2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for VRK2 from the curated Hub Proteins Protein-Protein Interactions dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with VRK2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for VRK2 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of VRK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of VRK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of VRK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Kinase Library Serine Threonine Kinome Atlas kinases that phosphorylate VRK2 protein from the Kinase Library Serine Threonine Atlas dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of VRK2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of VRK2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with VRK2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of VRK2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of VRK2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of VRK2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of VRK2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing VRK2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain VRK2 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of VRK2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of VRK2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of VRK2 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing VRK2 protein recovered by IP-MS from the NURSA Protein Complexes dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for VRK2 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of VRK2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of VRK2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving VRK2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving VRK2 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2014 pathways involving VRK2 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving VRK2 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of VRK2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of VRK2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of VRK2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at VRK2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of VRK2 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of VRK2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of VRK2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with VRK2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of VRK2 gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of VRK2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of VRK2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of VRK2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of VRK2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of VRK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of VRK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of VRK2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with VRK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with VRK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.